PROCEPT BioRobotics (PRCT) Net Cash Flow Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 76.43% |
| 10 | PROCEPT BioRobotics | 978.77 Mn | 733.13 Mn | 53.95 Mn | -133.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.01% |
| Dec 31, 2025 | -105.65% |
| Sep 30, 2025 | 51.38% |
| Jun 30, 2025 | -17.28% |
| Mar 31, 2025 | 44.64% |
| Dec 31, 2024 | 546.98% |
| Sep 30, 2024 | -112.61% |
| Jun 30, 2024 | 63.29% |
| Mar 31, 2024 | 22.60% |
| Dec 31, 2023 | -12.00% |
| Sep 30, 2023 | 767.36% |
| Jun 30, 2023 | -116.00% |
| Mar 31, 2023 | -140.58% |
| Dec 31, 2022 | -69.25% |
| Sep 30, 2022 | -112.77% |
| Jun 30, 2022 | -119.81% |
| Mar 31, 2022 | -21.29% |
| Dec 31, 2021 | -22.30% |